A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy

Journal:

Ophthalmology

Published:

2025-08-15

DOI:

10.1016/j.ophtha.2025.07.039

Affiliations:

7

Authors:

8

Go to article

Institutions	Authors	Share
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	2.285714	0.29
New York Eye and Ear Infirmary of Mount Sinai (NYEE), MSHS, United States of America (USA)	1.142857	0.14
McGill University, Canada	1.142857	0.14
Johns Hopkins University (JHU), United States of America (USA)	1.142857	0.14
Kaiser Permanente Northern California, United States of America (USA)	1.142857	0.14
Quark Pharmaceuticals, Inc., Israel	1.142857	0.14

Interested in Ophthalmology and Optometry?